Assignee
CENTRE LEON BERARD
FR·4 granted patents·6 pending applications·0 citations·filing 2012–2022
Top patents by PatentIndex Score
10 records- 0159US12509465B2Benzoimidazole derivatives as anticancer agentsCENTRE LEON BERARD·Filed 2022·Granted Dec 30, 2025·0 cites·17 claims
- 0257US2025283092A1Mirna combination for the prevention and treatment of cancerCENTRE LEON BERARD·Filed 2022·Application pending·0 cites
- 0350US2024102100A1Ribosomal rnas 2'o-methylation as a novel source of biomarkers relevant for diagnosis, prognosis and therapy of cancersCENTRE LEON BERARD·Filed 2021·Application pending·0 cites
- 0449US2021330774A1Herv-k-derived antigens as shared tumor antigens for anti-cancer vaccineCENTRE LEON BERARD·Filed 2019·Application pending·0 cites
- 0546US11384081B2Benzoimidazole derivatives as anticancer agentsCENTRE LEON BERARD·Filed 2017·Granted Jul 12, 2022·0 cites·15 claims
- 0638US2020232974A1Lymphocytes expressing cd73 in cancerous patient dictates therapyCENTRE LEON BERARD·Filed 2017·Application pending·0 cites
- 0736US12371402B2Mitochondrial activity inhibitors targeting tumoral metabolismCENTRE LEON BERARD·Filed 2019·Granted Jul 29, 2025·0 cites·13 claims
- 0836US2019292546A1Tlr3 agonist for use for inducing apoptosis in senescent cancer cellsCENTRE LEON BERARD·Filed 2017·Application pending·0 cites
- 0934US9683986B2Treatment of cancer by inhibition of the MYD88/ERK MAP kinase interactionCENTRE LEON BERARD·Filed 2012·Granted Jun 20, 2017·0 cites·10 claims
- 1023US2016369242A1Method for producing induced pluripotent cellsCENTRE LEON BERARD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CENTRE LEON BERARD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →